Kania, Brooke and Mekheal, Erinie and Roman, Sherif and Mekheal, Nader and Kumar, Vinod and Maroules, Michael (2022) Unintentional Dual Benefit: Improvement in Secondary Polycythemiain a Patient Receiving Chemotherapy for Metastatic Clear Cell RenalCell Carcinoma. European Journal of Case Reports in Internal Medicine, 9 (2). pp. 1-4. ISSN 2284-2594
|
Text
3125-Article Text-27518-1-10-20220216.pdf - Published Version Download (985kB) | Preview |
Abstract
Complete blood counts are frequently collected from cancer patients, but laboratory findings may be misleading. Secondary polycythemia can occur in renal cell carcinoma (RCC) due to erythropoietin (EPO) stimulation. Therefore, complete blood counts should be closely monitored to prevent complications such as thrombosis. We discuss the case of a 47-year-old man with metastatic RCC who presented with secondary polycythemia that improved with chemotherapy. His secondary erythrocytosis was anticipated, but his haemoglobin levels were lower than expected after therapy. This article discusses the treatment and diagnosis of secondary polycythemia in patients with RCC.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Metastatic renal cell carcinoma, everolimus, paraneoplastic syndrome, secondary polycythemia, EPO-producing tumour |
| Subjects: | 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) |
| Depositing User: | Marina Spanti |
| Date Deposited: | 14 Apr 2022 12:32 |
| Last Modified: | 14 Apr 2022 12:32 |
| URI: | http://eprints.bice.rm.cnr.it/id/eprint/21794 |
Actions (login required)
 |
View Item |
